Literature DB >> 30978305

Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence.

Michael W Graner1.   

Abstract

High-grade gliomas, particularly glioblastomas (grade IV), are devastating diseases with dismal prognoses; afflicted patients seldom live longer than 15 months, and their quality of life suffers immensely. Our current standard-of-care therapy has remained essentially unchanged for almost 15 years, with little new therapeutic progress. We desperately need a better biologic understanding of these complicated tumors in a complicated organ. One area of rejuvenated study relates to extracellular vesicles (EVs)-membrane-enclosed nano- or microsized particles that originate from the endosomal system or are shed from the plasma membrane. EVs contribute to tumor heterogeneity (including the maintenance of glioma stem cells or their differentiation), the impacts of hypoxia (angiogenesis and coagulopathies), interactions amid the tumor microenvironment (concerning the survival of astrocytes, neurons, endothelial cells, blood vessels, the blood-brain barrier, and the ensuing inflammation), and influences on the immune system (both stimulatory and suppressive). This article reviews glioma EVs and the ways that EVs manifest themselves as autocrine, paracrine, and endocrine factors in proximal and distal intra- and intercellular communications. The reader should note that there is much controversy, and indeed confusion, in the field over the exact roles for EVs in many biological processes, and we will engage some of these difficulties herein.

Entities:  

Keywords:  astrocytes; brain tumor; exosomes; extracellular vesicles; glioma; immune response; inflammation; microenvironment; microvesicles

Mesh:

Year:  2019        PMID: 30978305      PMCID: PMC6717010          DOI: 10.1146/annurev-genom-083118-015324

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  163 in total

Review 1.  Revisiting the road to the discovery of exosomes.

Authors:  Rose M Johnstone
Journal:  Blood Cells Mol Dis       Date:  2005 May-Jun       Impact factor: 3.039

2.  A genetically tractable model of human glioma formation.

Authors:  J N Rich; C Guo; R E McLendon; D D Bigner; X F Wang; C M Counter
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

3.  Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

Authors:  D W Andrews; M Resnicoff; A E Flanders; L Kenyon; M Curtis; G Merli; R Baserga; G Iliakis; R D Aiken
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

4.  Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.

Authors:  Barbara A Sullivan; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

5.  Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers.

Authors:  Michael W Graner; Yi Zeng; Hanping Feng; Emmanuel Katsanis
Journal:  Cancer Immunol Immunother       Date:  2003-02-18       Impact factor: 6.968

6.  Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

Authors:  David A Reardon; Gamal Akabani; R Edward Coleman; Allan H Friedman; Henry S Friedman; James E Herndon; Roger E McLendon; Charles N Pegram; James M Provenzale; Jennifer A Quinn; Jeremy N Rich; James J Vredenburgh; Annick Desjardins; Sridharan Gururangan; Sri Guruangan; Michael Badruddoja; Jeanette M Dowell; Terence Z Wong; Xiao-Guang Zhao; Michael R Zalutsky; Darell D Bigner
Journal:  J Clin Oncol       Date:  2006-01-01       Impact factor: 44.544

7.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.

Authors:  Duc M Le; Arnaud Besson; Darrin K Fogg; Kyu-Sil Choi; David M Waisman; Cynthia G Goodyer; Barry Rewcastle; V Wee Yong
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

Review 9.  Circulating endothelial cells in malignant disease.

Authors:  Patrick K Y Goon; Christopher J Boos; Paul S Stonelake; Gregory Y H Lip
Journal:  Future Oncol       Date:  2005-12       Impact factor: 3.404

10.  Some features of the submicroscopic morphology of synapses in frog and earthworm.

Authors:  E D DE ROBERTIS; H S BENNETT
Journal:  J Biophys Biochem Cytol       Date:  1955-01
View more
  5 in total

1.  Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream Analyses.

Authors:  Christina Coughlan; Kimberley D Bruce; Olivier Burgy; Timothy D Boyd; Cole R Michel; Josselyn E Garcia-Perez; Vanesa Adame; Paige Anton; Brianne M Bettcher; Heidi J Chial; Melanie Königshoff; Elena W Y Hsieh; Michael Graner; Huntington Potter
Journal:  Curr Protoc Cell Biol       Date:  2020-09

Review 2.  Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes.

Authors:  Lisa Nieland; Liza M Morsett; Marike L D Broekman; Xandra O Breakefield; Erik R Abels
Journal:  Trends Neurosci       Date:  2020-11-21       Impact factor: 13.837

3.  Performance Comparison of Deep Learning Autoencoders for Cancer Subtype Detection Using Multi-Omics Data.

Authors:  Edian F Franco; Pratip Rana; Aline Cruz; Víctor V Calderón; Vasco Azevedo; Rommel T J Ramos; Preetam Ghosh
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 4.  Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.

Authors:  Yunping Chen; Yan Jin; Nan Wu
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

5.  Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism.

Authors:  Ailiang Zeng; Zhiyun Wei; Rosalia Rabinovsky; Hyun Jung Jun; Rachid El Fatimy; Evgeny Deforzh; Ramil Arora; Yizheng Yao; Shun Yao; Wei Yan; Erik J Uhlmann; Alain Charest; Yongping You; Anna M Krichevsky
Journal:  iScience       Date:  2020-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.